Engineered antibodies to combat viral threats
- 18 November 2020
- journal article
- editorial
- Published by Springer Nature in Nature
- Vol. 588 (7838) , 398-399
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Fc-Engineering for Modulated Effector Functions—Improving Antibodies for Cancer TreatmentAntibodies, 2020
- Fc-optimized antibodies elicit CD8 immunity to viral respiratory infectionNature, 2020
- Top companies and drugs by sales in 2019Nature Reviews Drug Discovery, 2020
- There Is (Scientific) Strength in Numbers: A Comprehensive Quantitation of Fc Gamma Receptor Numbers on Human and Murine Peripheral Blood LeukocytesFrontiers in Immunology, 2020
- Influence of immunoglobulin isotype on therapeutic antibody functionBlood, 2016
- Fc receptors and their influence on efficacy of therapeutic antibodies for treatment of viral diseasesExpert Review of Anti-infective Therapy, 2015
- Lymphoma depletion during CD20 immunotherapy in mice is mediated by macrophage FcγRI, FcγRIII, and FcγRIVBlood, 2008
- Fcγ receptors as regulators of immune responsesNature Reviews Immunology, 2008
- Monoclonal antibody-mediated enhancement of dengue virus infectionin vitroandin vivoand strategies for preventionProceedings of the National Academy of Sciences, 2007
- High Resolution Mapping of the Binding Site on Human IgG1 for FcγRI, FcγRII, FcγRIII, and FcRn and Design of IgG1 Variants with Improved Binding to the FcγRJournal of Biological Chemistry, 2001